First Light Diagnostics is developing rapid antimicrobial susceptibility tests (AST) to determine the optimal antibiotic to treat infections in hours, instead of days, as is the current practice. In addition to improving patient outcomes, the availability of the company’s rapid ASTs contribute to the attenuation of multidrug-resistant pathogens, a growing global problem.